Latest News Releases From The Newsroom
In the Spotlight: Fluor's Earnings and Tupperware's Debt Moves Share the Stage
August 04th, 2023
Fluor Corporation (NYSE: FLR) has reported adjusted earnings per share (EPS) of $0.76 for the second quarter of 2023, with revenues totaling $3.94 billion. These results significantly surpassed the consensus estimate of $0.43 EPS on revenues of $3.68. Read more
Mesoblast Faces Regulatory Setback; Nikola's Earnings: A Preview
August 04th, 2023
Mesoblast Limited (Nasdaq: MESO) has announced the receipt of a comprehensive response from the US Food and Drug Administration (FDA) regarding its Biologics License Application (BLA) resubmission for remestemcel-L. The FDA's response stipulates the . Read more
Exceeding Forecasts: Booking Holdings and Trupanion's Q2 Earnings
August 03rd, 2023
Shares of Booking Holdings Inc. (Nasdaq: BKNG) experienced a remarkable after-hours surge of over 10% following the release of its second-quarter 2023 financial results. The company outperformed expectations with an earnings per share (EPS) of $37. Read more
SEC Obtains Emergency Relief to Halt Utah-Based Company's Crypto Asset Fraud Scheme Involving 18 Defendant
August 03rd, 2023
FOR IMMEDIATE RELEASE 2023-146 Washington D.C. / CRWE PRESS RELEASE / Aug. 3, 2023 - The Securities and Exchange Commission today announced that it obtained a temporary asset freeze, restraining order, and other emergency relief agains. Read more
NeuBase Makes Strategic Move; EZ Detect's Expanded Reach Fuels Biomerica
August 03rd, 2023
NeuBase Therapeutics, Inc. (Nasdaq: NBSE) announced a pause in its program development. Instead, NeuBase will explore strategic options, including acquisitions, mergers, and other transactions, with the goal of maximizing shareholder value. Accord. Read more
Q2 Earnings: Regeneron and Cigna Outperform Expectations
August 03rd, 2023
Shares of Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) surged over 5% in pre-market trading following an impressive second quarter 2023 earnings report. The company exceeded expectations, reporting adjusted earnings per share (EPS) of $10.24 and re. Read more
Earnings Showdown: Murphy Oil Beats Estimates, Spirit Airlines Falls Short
August 03rd, 2023
Murphy Oil Corporation (NYSE: MUR) announced its second quarter 2023 financial results, revealing adjusted earnings per share (EPS) of $0.79 and revenues of $814.59 million. The company's performance exceeded the consensus estimate of $0.78 on revenu. Read more
$7.5M Stock Buyback Ignites Equillium; Upbeat Earnings Boost Upwork
August 03rd, 2023
Shares of Equillium, Inc. (Nasdaq: EQ) surged in the extended session after the company announced an up to $7.5 million stock buyback program. $EQ was trading at $0.96 in after-hours, up $0.21 (+28.01%) In other news, Upwork Inc. (Nasdaq: UPWK). Read more
CVS Health Posts Upbeat Earnings, Johnson Controls Mixed Results
August 02nd, 2023
CVS Health Corporation (NYSE: CVS) announced second quarter 2023 adjusted earnings per share (EPS) of $2.21 and recorded revenues of $88.92 billion, surpassing the consensus EPS estimate of $2.11 on revenues of $86.45 billion. The company confirme. Read more
Waters and DuPont Beat Estimates, Unveil Below-Consensus Outlook
August 02nd, 2023
Waters Corporation (NYSE: WAT) delivered strong second quarter 2023 results, reporting earnings per share (EPS) of $2.80 and revenues of $740.58 million, surpassing the consensus EPS estimate of $2.59 on revenue of $734.45 million. Looking ahead, . Read more
Want To Find Some News?
News By Industries
Recent Posts
-
Treasury Targets Family Members and Associates of Maduro Regime
December 20th, 2025Herbal Works Inc. Supports President Trump's Order Easing Restriction on Cannabis
December 18th, 2025Herbal Works Inc. Plans on Expansion of Product Line in 2026
December 18th, 2025December 17th, 2025Crown Equity Holdings Inc. Announces Changes to Board of Directors
December 16th, 2025




Member Login